More Articles
Heart failure (HF) patients face a higher risk of cancer and cancer-related mortality, according to a new analysis in JACC: CardioOncology.[1]…
Telehealth follow-up appointments can boost care for heart failure (HF) patients, according to a new study published in the Journal of the American Heart…
Pfizer has completed its $6.7 billion acquisition of Arena Pharmaceuticals, finalizing a deal that involves multiple cardiovascular properties. The transaction was first announced back in December 2021.
…
An advanced artificial intelligence (AI) algorithm examining electrocardiograms (ECG) can help clinicians diagnose and treat hypertrophic cardiomyopathy (HCM), according to a new study published in the Journal of the American…
David Bennett, the first patient to receive a genetically modified pig heart has died. He was 57 years old.
The modified pig heart…
Several weeks after cardiac surgeons …
Cardiac resynchronization therapy with a defibrillator (CRT-D) is associated with “significant improvements” in mortality and heart failure (HF) hospitalization…
COVID-19 vaccination does not increase a patient’s risk of visiting the emergency department (ED) for significant cardiac issues such as myocarditis or myocardial…
The U.S. Food and Drug Administration (FDA) has approved empagliflozin (Jardiance) as a treatment option for reducing the risk of cardiovascular mortality and hospitalization among adult…
Abbott has received an expanded FDA approval for its CardioMEMs HF System, making the solution…
Empagliflozin is associated with reducing the risk of heart failure (HF) hospitalization among patients presenting with a broad range of ejection fractions,…
The REDUCE LAP-HF II randomized clinical trial for the Corvia Atrial Shunt in…
The universal use of antibiotic-eluting envelopes (AEEs) during cardiac implantable electronic device (CIED) procedures for patients with heart failure with reduced…
Metformin initiation is independently associated with improved clinical outcomes among patients with both heart failure (HF) and diabetes, according to a new study published in JACC: Heart Failure.…
Outcomes are improving among older heart failure (HF) patients, according to a new study in Circulation: Heart Failure. In addition, healthcare costs associated with HF also appear to be on the decline…
Hoping to explore the economic burden of heart failure (HF) for both patients and healthcare systems, the Heart Failure Society of America (HFSA) has released a new analysis…
Male and female heart failure (HF) patients face an elevated risk of cancer, according to a new study published in JACC: CardioOncology…
COVID-19, especially the omicron variant, is still surging through the United States, putting a tremendous strain on the nation’s healthcare systems.
…
When treating older heart failure (HF) patients, cardiac resynchronization therapy with a defibrillator (CRT-D) is associated with better outcomes than treatment with an implantable cardioverter-defibrillator (ICD)…
A genetically modified pig heart was transplanted into a human patient for the very first time on Friday, Jan. 7, at the University of Maryland Medical Center (UMMC) in Baltimore. The 57-year-…
Dapagliflozin lowered the risk of deteriorating heart failure and cardiovascular death while improving symptoms in Black and white patients, according to new data published in JACC: Heart Failure.…